跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 200 条关于
“Mikasa Seiyaku”
全部
200
临床试验
155
药物
7
机构
20
资讯
18
昨天
AFT Pharmaceuticals Licenses Non-Opioid Maxigesic IV to Mikasa Seiyaku for Japan
4个月前
AGC Biologics Partners with Teikoku Seiyaku for Novel rhMMP-7 Therapy Manufacturing to Treat Lumbar Disc Herniation
上个月
Energenesis Biomedical and Taiwan Tanabe Seiyaku Enter Joint Development Agreement for Diabetic Foot Ulcer Candidate ENERGI-F703DFU
9个月前
MEDIPOST Secures $140 Million Funding and Japan Partnership to Advance Stem Cell Therapy for Knee Osteoarthritis
去年
Ainos and Taiwan Tanabe Partner to Advance VELDONA® for Sjögren's Syndrome
11天前
Sandoz Licenses Emicizumab Biosimilar From mAbxience, Adding First Haemophilia Asset to 40-Drug Pipeline
2年前
Fresenius Kabi Launches First Actemra® Biosimilar in U.S. Market as Biosimilar Landscape Expands
去年
Ainos Advances VELDONA Oral Interferon Platform with Dual Clinical Trial Approvals for Rare Diseases
去年
PIKASO Trial Investigates Metformin for Preventing Post-ACL Surgery Osteoarthritis
去年
The PIKASO Trial: A New Hope for Preventing Post-Traumatic Osteoarthritis
第 1 页,共 2 页
上一页
下一页